Q3 2017 Earnings Estimate for Stericycle, Inc. Issued By Northcoast Research (SRCL)
Stericycle, Inc. (NASDAQ:SRCL) – Analysts at Northcoast Research lowered their Q3 2017 earnings estimates for Stericycle in a research report issued to clients and investors on Friday. Northcoast Research analyst E. Snyder now expects that the business services provider will earn $1.13 per share for the quarter, down from their previous forecast of $1.17. Northcoast Research also issued estimates for Stericycle’s Q4 2017 earnings at $1.20 EPS, FY2017 earnings at $4.57 EPS, Q1 2018 earnings at $1.24 EPS, Q2 2018 earnings at $1.07 EPS, Q3 2018 earnings at $1.17 EPS and Q4 2018 earnings at $1.23 EPS.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.02. The firm had revenue of $917.70 million during the quarter, compared to analysts’ expectations of $902.81 million. Stericycle had a positive return on equity of 14.23% and a negative net margin of 0.07%. Stericycle’s revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.18 earnings per share.
TRADEMARK VIOLATION NOTICE: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/08/07/q3-2017-earnings-estimate-for-stericycle-inc-issued-by-northcoast-research-srcl.html.
Other equities research analysts also recently issued reports about the company. Deutsche Bank AG cut their target price on Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, May 15th. Jefferies Group LLC set a $108.00 target price on Stericycle and gave the stock a “buy” rating in a research report on Saturday, May 6th. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research report on Tuesday, April 25th. BMO Capital Markets initiated coverage on Stericycle in a research report on Thursday, June 29th. They issued a “market perform” rating and a $81.00 target price for the company. Finally, Barclays PLC initiated coverage on Stericycle in a research report on Thursday, April 13th. They issued an “overweight” rating and a $100.00 target price for the company. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company. Stericycle has an average rating of “Hold” and an average target price of $81.15.
Stericycle (NASDAQ SRCL) opened at 78.45 on Monday. The firm has a market capitalization of $6.69 billion, a PE ratio of 40.88 and a beta of 0.13. Stericycle has a one year low of $71.52 and a one year high of $90.45. The company’s 50-day moving average price is $76.84 and its 200 day moving average price is $80.67.
Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock worth $421,877,000 after buying an additional 4,947,900 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Stericycle by 144.9% in the first quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock worth $157,594,000 after buying an additional 1,124,908 shares during the period. Wedge Capital Management L L P NC bought a new stake in shares of Stericycle during the first quarter worth approximately $43,949,000. Wells Fargo & Company MN increased its stake in shares of Stericycle by 25.5% in the first quarter. Wells Fargo & Company MN now owns 1,956,193 shares of the business services provider’s stock worth $162,149,000 after buying an additional 398,076 shares during the period. Finally, Jennison Associates LLC increased its stake in shares of Stericycle by 32.7% in the first quarter. Jennison Associates LLC now owns 1,417,498 shares of the business services provider’s stock worth $117,496,000 after buying an additional 349,371 shares during the period. Institutional investors own 95.12% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.